Neuromodulatory and anti-inflammatory ingredient for sensitive skin: In vitro assessment

Inflammation and Allergy - Drug Targets

Volumn 13, Issue 3, 2014, Pages 191-198

  Costa, Adilson ^a,b   Eberlin, Samara ^a   Polettini, Anelise J ^a   da Costa Pereira, Andreia F ^c   Pereira, Caroline S ^b   Cortés Ferreira, Nayara M ^a   Dolis, Eleonora ^c   Oliveira Torloni, Liliana B ^d  

^a KOLderma Clinical Trials Institute   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c CECI Innovation and Consumer Studies Center   (Brazil)

^d Hypermarcas S/A ^*  (Brazil)

Author keywords

Envelope proteins; Neurogenic inflammation; Neuropeptide; POMC; Sensitive skin; TRPV1

Indexed keywords

BETA ENDORPHIN; ENKEPHALIN; FILAGGRIN; HISTAMINE; INTERLEUKIN 1ALPHA; INVOLUCRIN; LEUKOTRIENE B4; PROSTAGLANDIN E2; SUBSTANCE P; VANILLOID RECEPTOR 1; ANTIINFLAMMATORY AGENT; SENSC; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; AUTACOID; DERMATOLOGICAL AGENT; ICOSANOID; NEUROPEPTIDE; TRPV1 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS CELL; HUMAN; HUMAN CELL; INTEGUMENTARY SYSTEM; NEUROMODULATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SENSITIVE SKIN; SKIN; CELL CULTURE; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; KERATINOCYTE; MALE; METABOLISM; PATHOLOGY;

ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; DERMATOLOGIC AGENTS; EICOSANOIDS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KERATINOCYTES; MALE; NEUROPEPTIDES; SKIN; TRPV CATION CHANNELS;

EID: 84904094332     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528113666140616112708     Document Type: Article

References (56)

1. Amin, S.; Maibach, H.I. Cosmetic intolerance syndrome: pathophysiology and management. Cosmet. Dermatol., 1996, 9, 34-42.
2. Willis, C.M.; Shaw, S.; De Lacharriere, O.; Baverel, M.; Reiche, L.; Jourdain, R.; Bastien, P.; Wilkinson, J.D. Sensitive skin: an epidemiological study. Br. J. Dermatol., 2001, 145, 258-253.
3. Draelos, Z.D. Sensitive skin: perceptions, evaluation, and treatment. Am. J. Cont. Dermatol., 1997, 8, 67-78.
4. Kueper, T.; Krohn, M.; Haustedt, L.O.; Hatt, H.; Schmaus, G.; Vielhaber, G. Inhibition of TRPV1 for the treatment of sensitive skin. Exp. Dermatol., 2010, 19: 980-986.
5. Sandilands, A.; Sutherland, C.; Irvine, A.D.; McLean, W.H.I. Filaggrin in the frontline: role in skin barrier function and disease. J. Cell Sci., 2009, 122, 1285-1294.
6. Hara, M.; Ma, T.; Verkman, A.S. Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery. J. Biol. Chem., 2002, 227, 46616-46621.
7. Ishida-Yamamoto, A.; Iizuka, H. Structural organization of cornified cell envelopes and alterations in inherited skin disorders. Exp. Dermatol., 1998, 7, 1-10.
8. Yosipovitch, G.; Yarnitzky, D. Quantitative sensory testing. In: Dermatotoxicology Methods: The Laboratory Worker's Vade Mecum; Maibach, H.I., Marzulli, F.N., Eds.; Taylor & Francis: New York, 1997, pp. 120-135.
9. Pons-Guiraud, A. Sensitive skin: a complex and multifactorial syndrome. J. Cosm. Dermatol., 2004, 3, 145-148.
10. Williams, I.R.; Kupper, T.S. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci., 1996, 58, 1485-1507.
11. Kupper, T.S.; Fuhlbrigge, R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nature, 2004, 4, 211-222.
12. Kupper, T.S. T cells, immunosurveillance, and cutaneous immunity. J Dermatol Sci., 2000, 24 Suppl. 1, S41-S45.
13. Corsini, E.; Galli, C.L. Epidermal cytokines in experimental contact dermatitis. Toxicol., 2000, 142, 203-211.
14. Roosterman, D.; Goerge, T.; Schneider, S.W.; Bunnett, N.W.; Steinhoff, M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev., 2006, 86, 1309-1379.
15. Paus, R.; Theoharides, T.C.; Arck, P.C. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol., 2006, 27, 32-39.
16. Torloni, L.B.O.; Dieamant, G.C. Pele Sensível. In: Tratado Internacional de Cosmecêuticos; Costa, A; Guanabara Koogan: Rio de Janeiro, 2012, pp. 118-123.
17. Corsini, E.; Galli, C.L. Cytokines and irritant contact dermatitis. Toxicol. Lett., 1998, 102-103, 277-282.
18. Luger, T.A. Neuromediators - a crucial component of the skin immune system. J. Dermatol. Sci., 2002, 30, 87-93.
19. Grouzmann, E.; Bigliardi, P.; Appenzeller, M.; Pannatier, A.; Buclin, T. Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers. Biol. Chem., 2011, 392, 217-221.
20. Misery, L.; Myon, E.; Martin, N.; Consoli, S.; Bousetta, S.; Nocera, T.; Taieb, C. Sensitive skin: psychological effects and seasonal changes. J. Eur. Acad. Dermatol. Venereol., 2007, 21, 620-628.
21. Jourdain, R.; De Lacharriere, O.; Bastien, P.; Maibach, H.I. Ethnic variations in self-perceived sensitive skin: epidemiological survey. Cont. Dermat., 2002, 46, 162-169.
22. Jourdain, R.; Bastien, P.; De Lacharriere, O.; Rubinstenn, G. Detection thresholds of capsaicin: a new test to assess facial skin neurosensitivity. J. Cosmet. Sci., 2005, 56, 153-166.
23. Clapham, D.E. TRP channels as cellular sensors. Nature, 2003, 426, 517-524.
24. Chuang, H.H.; Prescott, E.D.; Kong, H.; Shields, S.; Jordt, S.E.; Basbaum, A.I.; Chao, M.V.; Julius, D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns (4,5) P2-mediated inhibition. Nature, 2001, 411, 957-962.
25. Moriyama, T.; Higashi, T.; Togashi, K.; Iida, T.; Segi, E.; Sugimoto, Y.; Tominaga, T.; Narumiya, S.; Tominaga, M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain, 2005, 1, doi:10.1186/1744-8069-1-3.
26. Aubdool, A.A.; Brain, S.D. Neurovascular aspects of skin neurogenic inflammation. J. Invest. Dermatol. Symp. Proc., 2011, 15, 33-39.
27. Steinhoff, M.; Bienenstock, J.; Schmelz, M.; Maurer, M.; Wei, E.; Bíro, T. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J. Invest. Dermatol., 2006, 126, 1705-1718.
28. Nissen, J.B.; Avrach, W.W.; Hansen, E.S.; Stengaard-Pedersen, K.; Kragballe, K. Increased levels of enkephalin following natural sunlight (combined with salt water bathing at the Dead Sea) and ultraviolet irradiation. Br. J. Dermatol., 1998, 139, 1012-1019.
29. Bigliardi, P.L.; Sumanovski, L.T.; Büchner, S.; Rufli, T.; Bigliardi-Qi, M. Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression. J. Invest. Dermatol., 2003, 120, 145-152.
30. Kamatou, G.P.P.; Viljoen, A.M. A review of the application and pharmacological properties of α-bisabolol-rich oils. J. Am. Oil Chem. Soc., 2010, 87, 1-7.
31. Surh, Y.J. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res., 1999, 428, 305-327.
32. Hosipovitch, G. Evaluating subjective irritation and sensitive skin. Cosm. Toil., 1999, 114, 41-42.
33. Goldsmith, L.A. Physiology, biochemistry and molecular biology of the skin, 2nd ed.; Oxford University Press: New York, 1991.
34. Manna, S.K.; Aggarwal, B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol., 1998, 161, 2873-2880.
35. Scholzen, T.E.; Brzoska, T.; Kalden, D.H. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation. J. Invest. Dermat. Symp. Proc., 1999, 4, 55-60.
36. Shim, W.S.; Tak, M.H.; Lee, M.H.; Kim, M.; Kim, M.; Koo, J.Y.; Lee, C.H.; Kim, M.; Oh, U. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J. Neurosci., 2007, 7, 2331-2337.
37. Bienenstock, J.; Tomioka, M.; Stead, R.; Ernst, P.; Jordana, M.; Gauldie, J.; Dolovich, J.; Denburg, J. Mast cell involvement in various inflammatory processes. Am. Rev. Respir. Dis., 1987, 135, S5-S8.
38. Maurer, M.; Theoharides, T.; Granstein, R.D.; Bischoff, S.C.; Bienenstock, J.; Henz, B.; Kovanen, P.; Piliponsky, A.M.; Kambe, N.; Vliagoftis, H.; Levi-Schaffer, F.; Metz, M.; Miyachi, Y.; Befus, D.; Forsythe, P.; Kitamura, Y.; Galli, S. What is the physiological function of mast cells? Exp. Dermatol., 2003, 12, 886-910.
39. Sadofsky, L.R.; Ramachandran, R.; Crow, C.; Cowen, M.; Compton, S.J.; Morice, A.H. Inflammatory stimuli up-regulate transient receptor potential vanilloid-1 expression in human bronchial fibroblasts. Exp. Lung Res., 2012, 38, 75-81.
40. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389, 816-824.
41. Trevisani, M.; Gazzieri, D.; Benvenuti, F.; Campi, B.; Dinh, Q.T.; Groneberg, D.A.; Rigoni, M.; Emonds-Alt, X.; Creminon, C.; Fischer, A.; Geppetti, P.; Harrison, S. Ethanol causes inflammation in the airways by a neurogenic and TRPV1-dependent mechanism. J. Pharmacol. Exp. Ther., 2004, 309, 1167-1173.
42. Veronesi, B.; Carter, J.D.; Devlin, R.B.; Simon, S.A.; Oortgiesen, M. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides, 1999, 33, 447-456.
43. Inoue, K.; Koizumi, S.; Fuziwara, S.; Denda, S.; Denda, M. Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem. Biophys. Res. Commun., 2002, 291, 124-129.
44. Miyamoto, R.; Tokuda, M.; Sakuta, T.; Nagaoka, S.; Torii, M. Expression and characterization of vanilloid receptor subtype 1 in human dental pulp cell cultures. J. Endod., 2005, 31, 652-658.
45. Southall, M.D.; Li, T.; Gharibova, L.S.; Pei, Y.; Nicol, G.D.; Travers, J.B. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J. Pharmacol. Exp. Ther., 2003, 304, 217-222.
46. Engler, A.; Aeschlimann, A.; Simmen, B.R.; Michel, B.A.; Gay, R.E.; Gay, S.; Sprott, H. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem. Biophys. Res. Commun., 2007, 359, 884-888.
47. Dieamant, G.C.; Pereda, M.C.V.; Eberlin, S.; Nogueira, C.; Werka, R.M.; Queiroz, M.L.S. Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment. J. Cosm. Dermatol., 2008, 7, 112-119.
48. Marks, R. The Stratum corneum barrier: the final frontier. J. Nutr., 2004, 134, 2017S-2021S.
49. Kalinin, A.; Marekov, L.N.; Steinert, P.M. Assembly of the epidermal cornified cell envelope. J. Cell Sci., 2001, 114, 3069-3070.
50. Sugarman, J.L.; Fluhr, J.W.; Fowler, A.J.; Bruckner, T.; Diepgen, T.L.; Williams, M.L. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and Stratum corneum hydration with computer-assisted estimates for extent of disease. Arch. Dermatol., 2003, 139(11), 1417-1422.
51. Steinert, P.M.; Marekov, L.N. Direct evidence that involucrin is a major early isopeptide crosslinked component of the keratinocyte cornified cell envelope. J Biol. Chem., 1997, 272, 2021-2030.
52. Eckert, R.L.; Welter, J.F. Transcription factor regulation of epidermal keratinocyte gene expression. Mol. Biol. Rep., 1996, 23, 59-70.
53. Eckert, R.L.; Yaffe, M.B.; Crish, J.F.; Murthy, S.; Rorke, E.A.; Welter, J.F. Involucrin - structure and role in envelope assembly. J. Invest. Dermatol., 1993, 100, 613-617.
54. Watson, W.; Kapur, S. Atopic dermatitis. Allergy, Asthma Clinic. Immunol., 2011, 7(1), S4, 1-7.
55. Morizot, F.; Guinot, C.; Lopez, S.; Le Fur, I.; Tschachler, E.; Wood, C. Sensitive skin: analysis of symptoms, perceived causes and possible mechanisms. Cosmet. Toil., 2000, 115, 83-89.
56. Pereda, M.C.V.; Dieamant, G.C.; Eberlin, S.; Werka, R.M.; Colombi, D.; Queiroz, M.L.S.; Di Stasi, L.C. Expression of differential genes involved in the maintenance of water balance in human skin by Piptadenia colubrina extract. J. Cosm. Dermatol., 2010, 9, 35-43.